Painkillers 'prevent prostate cancers'

Key points
- Men who take certain types of painkiller may be lowering their risk of developing prostate cancer, says a scientific study.
- The older the patient, the more apparent protection was offered by the painkillers.
- Prostate cancer has become one of the most commonly-diagnosed cancers in elderly men.
- However, the results are not enough to convince even the researchers involved in the study that millions of elderly men should be getting the drugs.
Men who take certain types of painkiller may be lowering their risk of developing prostate cancer, says a scientific study.
It is possible they do this by reducing inflammation which has been linked to cancerous tissue changes.
However, the results are not enough to convince even the researchers involved in the study that millions of elderly men should be getting the drugs.
Some patients react badly to long-term painkiller use, suffering gastric bleeding and liver problems - and there is no guarantee that the benefits to one group of patients would outweigh the risks to another.
The researchers, from the Mayo Clinic, looked at 1,362 men over a five and a half year period.
Some were given a regular dose of the type of painkillers called "non-steroidal anti-inflammatories" - which include ibuprofen and aspirin, while the rest were not.
Over the 66-month period, 9% of the non-treated group developed prostate cancer, while only 4% of those given the painkillers were diagnosed with the disease.
Right dose
The older the patient, the more apparent protection was offered by the painkillers.
This echoes similar, if not so pronounced, findings in both breast and colon cancer.
However, the researchers say that more work needs to be done to confirm the findings - and make sure that the drug would not do more harm than good.
Dr Rosebud Roberts, one of the researchers, said: "We also need to determine the duration and dosage use that provides protection against prostate cancer, and to better understand the biologic mechanisms underlying the association between NSAIDs and prostate cancer."
She plans additional research into African American men - who appear to have the highest prostate cancer risk - to see if the results can be reproduced there.
Screening controversy
Prostate cancer has become one of the most commonly-diagnosed cancers in elderly men.
It affects a small gland just below the bladder, which produces a component of semen.
While some of these cancers can be relatively slow-moving, not requiring drastic treatments or surgery, others are aggressive, spreading to other parts of the body if not caught early and treated.
Some doctors argue in favour of regular prostate screening using a blood test, although this is controversial, as it is feared some men might undergo unnecessary and potentially damaging surgery on the basis of "false positive" test results.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsVitamin E, Selenium and Soy in Combination Does Not Prevent Prostate Cancer
The combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer, according to the new research presented at the…
27 April 2009
News"Watchful waiting" safe for some prostate cancers
Carefully selected men with "low-risk" prostate cancer can safely delay treatment and opt instead for active surveillance, researchers report in the April issue of The Journal of Urology. With active surveillance, or…
2 April 2009
NewsEffect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
In the January 7, 2009 issue of the Journal of the American Medical Association, Dr. Scott Lippman and associates presented the results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT). This is a phase 3…




